Administrative Supplement to Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation
FABP 介导的内源性大麻素信号分子驱动食欲调节的行政补充
基本信息
- 批准号:10797598
- 负责人:
- 金额:$ 9.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-15 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAddressAdministrative SupplementAffinityAmidesAnimal ModelAnimalsAppetite RegulationApplications GrantsArticulationAutoimmune DiseasesBindingBinding ProteinsBinding SitesBiological AssayBiophysicsCell NucleusChemicalsChimera organismComplexDesire for foodDiffusionDissociationDrug DesignDrug ModulationEndocannabinoidsEnterocytesEnzymesEstersExhibitsFatty AcidsFluorescenceFood Intake RegulationFutureGenetic TranscriptionGlycerolHealthHeart DiseasesHumanHydrophobicityIn VitroInflammationIntestinesKnock-outKnockout MiceLigand BindingLigand Binding DomainLigandsLipaseLiverMeasuresMediatingMetabolicModelingMolecularMolecular ChaperonesMolecular ConformationMolecular StructureMonitorMusNMR SpectroscopyNon-Insulin-Dependent Diabetes MellitusNuclear ReceptorsObesityOutcomePainPatternPeroxisome Proliferator-Activated ReceptorsPeroxisome ProliferatorsPhenotypePhysiologicalProtein Binding DomainProteinsRegulationRelaxationResearchRiskRoleSatiationSignal TransductionSignaling MoleculeSiteSurface Plasmon ResonanceTestingThermodynamicsThinnessTitrationsUnderrepresented PopulationsUnited States National Institutes of HealthVertebral columnWorkcareerdesignendocannabinoid signalingexperimental studyfatty acid amide hydrolasefatty acid-binding proteinsheart disease riskin vitro testingmemberneuroprotectionpreferencepressureprogramsprotein complexprotein protein interactionreceptor bindingrecruitthyroid hormone receptor associated protein 220
项目摘要
Stark, Ruth E. Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation
Metabolic signaling by endogenous cannabinoids (ECs) is essential to the regulation of human
appetite, pain, and neuroprotection. Fatty acid-binding proteins (FABPs) can either sequester the
hydrophobic ECs or transport them to hydrolytic enzymes; ECs routed to the nucleus also activate the
peroxisome proliferator-activated receptors (PPARs). EC levels have been correlated with obesity in
knockout mice for liver (L) FABP that is co-expressed with intestinal (I) FABP in enterocytes and also for
PPARa knockouts, underscoring the regulatory roles of these proteins. We will probe poorly understood
EC-FABP, EC-PPAR, and FABP-EC-PPAR complexes in vitro at near-physiological concentrations,
determining affinities, metabolic fates, molecular binding interfaces, and conformational changes to test
mechanistic hypotheses regarding EC signaling. Trainees at multiple career stages, including those
recruited from underrepresented groups in STEM, will be integrally involved in this research program.
Specific questions to be addressed are as follows: (1) How do ECs choose between FABP
chaperones to produce obese or lean outcomes? The possibility that ECs are delivered by LFABP to
hydrolytic enzymes for metabolic breakdown rather than sequestered by IFABP in the enterocyte will be
tested enzymatically, whereas the rationale for LFABP’s diminished affinity will be explored using high-
pressure solution-state NMR to identify energetically favored candidate sites for binding. (2) Could
transcriptional activity be driven by EC binding preferences for LFABP vs. PPARa? The PPARa
ligand-binding domain (PPARa_LBD) will be purified, rigorously delipidated, and tested in vitro for EC-
modulated transcriptional activity. EC binding affinities will be compared for PPARa_LBD and FABPs.
(3) Could transcriptional activity be driven by EC-modulated FABP-PPAR collisions that cause
conformational changes? To determine the interactions involved in the proposed FABP-mediated EC
activation of PPARa transcriptional function, we will first use surface plasmon resonance to measure the
binding affinity of LFABP-PPARa_LBD protein complexes, on their own and in the presence of ligands
with a range of known activation efficacies. The site-specific collision-associated impact on the LFABP
partner will be probed by solution-state NMR spectroscopy of the [U-15N]-enriched protein, using chemical
shift perturbations of each backbone NH resonance to define the binding interface with PPARa_LBD, any
allosteric structural changes that occur upon complex formation, and their modulation by EC ligands. Taken
together, these experiments will advance our understanding of (macro)molecular networks that function to
achieve metabolic signaling by ECs involved in appetite and pain regulation, thereby advancing our
understanding of health risks related to obesity and inflammation. This understanding can guide the design
of drugs that modulate these biomedically important ligand-protein and protein-protein interactions.
NIH SuRE Grant Proposal
Stark,Ruth E. Fabp介导的内源性大麻素信号的分子驱动器,以调节食欲
内源性大麻素(EC)的代谢信号传导对于人类的调节至关重要
食欲,疼痛和神经保护作用。脂肪酸结合蛋白(Fabps)可以隔离
疏水性EC或将其运输到水解酶;路由到核的EC也激活了
过氧化物体增殖物激活受体(PPARS)。 EC水平与肥胖有关
肝(L)FABP的敲除小鼠,该肝脏与肠道(I)Fabp共表达肠肠细胞,也适用于肠道(I)
PPARA敲除,强调了这些蛋白质的调节作用。我们将探究不理解
EC-FABP,EC-PPAR和FABP-EC-PPAR络合物在近生物学浓度下体外,
确定亲和力,代谢命运,分子结合界面和构象变化以测试
关于EC信号传导的机械假设。在多个职业阶段的学员,包括
从STEM中代表性不足的群体中招募的招募将集成到该研究计划中。
要解决的具体问题如下:(1)EC在FABP之间的选择
伴侣产生肥胖或瘦肉结果? LFABP将EC的可能性交付给
用于代谢分解的水解酶,而不是由肠肠细胞中的IFABP隔离
通过酶法测试,而LFABP的亲和力降低的基本原理将使用高
压力溶液状态NMR可有效识别有利于候选位点进行结合。 (2)可以
转录活性由LFABP与PPARA的EC结合偏好驱动? PPARA
配体结合结构域(PPARA_LBD)将被纯化,严格分离,并在体外测试EC-
调制转录活性。将比较PPARA_LBD和FABPS的EC结合亲和力。
(3)转录活动可能是由EC调制的FABP-PPAR碰撞驱动的
构象变化?确定所提出的FABP介导的EC中涉及的相互作用
激活PPARA转录功能,我们将首先使用表面等离子体共振来测量
LFABP-PPARA_LBD蛋白复合物的结合亲和力本身并存在配体的存在
具有一系列已知的激活效率。特定地点相关的对LFABP的影响
伴侣将通过使用化学的[U-15N]富集蛋白的溶液状态NMR光谱探测
每个骨干NH共振的偏移扰动,以定义使用PPARA_LBD的绑定界面,任何
复杂形成后发生的变构结构变化及其对EC配体的调节。拍摄
这些实验将共同提高我们对(宏)分子网络的理解
通过涉及食欲和疼痛调节的EC实现代谢信号传导,从而提高了我们
了解与肥胖和炎症有关的健康风险。这种理解可以指导设计
调节这些生物医学重要的配体 - 蛋白质和蛋白质蛋白质相互作用的药物。
NIH确定的赠款提案
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUTH E. STARK其他文献
RUTH E. STARK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUTH E. STARK', 18)}}的其他基金
Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation
FABP 介导的内源性大麻素信号传导食欲调节的分子驱动因素
- 批准号:
10683375 - 财政年份:2022
- 资助金额:
$ 9.88万 - 项目类别:
Molecular Drivers of FABP-mediated Endocannabinoid Signaling for Appetite Regulation
FABP 介导的内源性大麻素信号传导食欲调节的分子驱动因素
- 批准号:
10410168 - 财政年份:2022
- 资助金额:
$ 9.88万 - 项目类别:
LIPID CONTROL IN THE REMOVAL OF DYING BRAIN TUMOR CELLS
去除垂死脑肿瘤细胞时的脂质控制
- 批准号:
6095696 - 财政年份:1998
- 资助金额:
$ 9.88万 - 项目类别:
LIPID CONTROL IN THE REMOVAL OF DYING BRAIN TUMOR CELLS
去除垂死脑肿瘤细胞时的脂质控制
- 批准号:
6325020 - 财政年份:1998
- 资助金额:
$ 9.88万 - 项目类别:
LIPID CONTROL IN THE REMOVAL OF DYING BRAIN TUMOR CELLS
去除垂死脑肿瘤细胞时的脂质控制
- 批准号:
6095697 - 财政年份:1998
- 资助金额:
$ 9.88万 - 项目类别:
LIPID CONTROL IN THE REMOVAL OF DYING BRAIN TUMOR CELLS
去除垂死脑肿瘤细胞时的脂质控制
- 批准号:
2611440 - 财政年份:1998
- 资助金额:
$ 9.88万 - 项目类别:
LIPID CONTROL IN THE REMOVAL OF DYING BRAIN TUMOR CELLS
去除垂死脑肿瘤细胞时的脂质控制
- 批准号:
6325021 - 财政年份:1998
- 资助金额:
$ 9.88万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Patterns and variation of opioid use in long-stay nursing home residents with dementia
患有痴呆症的长期入住疗养院居民的阿片类药物使用模式和变化
- 批准号:
9719244 - 财政年份:2016
- 资助金额:
$ 9.88万 - 项目类别: